ELIZABETH ANYANWU: Open Payments
NPI 1740526730 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 72 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $305 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 29 | $553 |
| Teva Pharmaceuticals USA, Inc. | 14 | $311 |
| Alkermes, Inc. | 9 | $201 |
| ABBVIE INC. | 9 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Neurocrine BioSciences, Inc. | 6 | $125 |
| Lundbeck LLC | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Almatica Pharma LLC | 1 | $22 |
Products named: REXULTI, UZEDY, AUSTEDO XR, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, INGREZZA.
Industry payments across CA — which companies pay providers there.
